These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis. Carrizosa J; Kobasa WD; Kaye D Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991 [TBL] [Abstract][Full Text] [Related]
9. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible Chan L; Chan-Tompkins NH; Como J; Guarascio AJ Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347 [No Abstract] [Full Text] [Related]
10. The choice of a parenteral panicillinase-resistant penicillin. Med Lett Drugs Ther; 1969 Apr; 11(8):35-6. PubMed ID: 5778362 [No Abstract] [Full Text] [Related]
11. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782 [TBL] [Abstract][Full Text] [Related]
12. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. MartÃnez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833 [TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Youngster I; Shenoy ES; Hooper DC; Nelson SB Clin Infect Dis; 2014 Aug; 59(3):369-75. PubMed ID: 24785233 [TBL] [Abstract][Full Text] [Related]
15. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia. Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442 [TBL] [Abstract][Full Text] [Related]
16. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Kopp BJ; Nix DE; Armstrong EP Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044 [TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis. Suh L; Coffin S; Leckerman KH; Gelfand JM; Honig PJ; Yan AC Pediatr Dermatol; 2008; 25(5):528-34. PubMed ID: 18950393 [TBL] [Abstract][Full Text] [Related]
19. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. Kaplan SL; Mason EO; Feigin RD South Med J; 1982 Feb; 75(2):138-42. PubMed ID: 7036354 [TBL] [Abstract][Full Text] [Related]
20. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]